ÌÇÐÄÆƽâ°æ

Moderna Inc.

Statistics report about biotech company Moderna

This report presents key facts and figures about U.S. biotech company Moderna. Moderna Inc. is well-known for the discovery of one of the first two COVID-19 vaccines which was available to the broader market. This report shows the company's role in global biotech, revenues, major products, and provides a focus chapter on the COVID-19 vaccine market.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Market overview

6
  • Premium Statistic Global biotech drug sales estimate 2012-2024
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2016-2030
  • Basic Statistic Major pharmaceutical products by sales worldwide 2025
  • Premium Statistic Forecasted revenue of mRNA market revenue worldwide 2021-2035
  • Premium Statistic Gross profit margin of select U.S. biotech and drug companies Q1-Q4 2025
  • Basic Statistic AI readiness of big pharma companies 2025

Key figures

5
  • Basic Statistic Moderna's revenue 2016-2025
  • Basic Statistic Moderna net income 2016-2024
  • Basic Statistic Moderna total assets 2016-2024
  • Basic Statistic R&D expenses of Moderna 2016-2024
  • Basic Statistic R&D expenses of Moderna by type 2025

Competitors

4
  • Basic Statistic Leading mRNA biotech companies' market cap 2026
  • Basic Statistic Revenue of BioNTech 2017-2025
  • Premium Statistic AstraZeneca's total revenue 2006-2025
  • Premium Statistic Pfizer revenue 2006-2025

Focus: COVID-19

8
  • Basic Statistic Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
  • Premium Statistic Forecasted COVID-19 vaccine revenue share globally by technology 2026
  • Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
  • Basic Statistic COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
  • Basic Statistic Comparison of select COVID-19 vaccines 2022, by efficacy
  • Premium Statistic Shareholdings at select COVID-19 vaccine companies by investor 2021
  • Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
  • Premium Statistic Share of Moderna COVID-19 vaccines delivered by country income group 2021
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch